Unique Challenges of Hepatitis C in Infants, Children, and Adolescents

Clin Ther. 2018 Aug;40(8):1299-1307. doi: 10.1016/j.clinthera.2018.07.010. Epub 2018 Aug 11.

Abstract

Purpose: Hepatitis C, a chronic disease with deadly consequences, is no longer predominantly a disease of older people.

Methods: A limited search was conducted of the relevant literature on 2 topics: (1) the impact of hepatitis C on infants exposed by vertical transmission; and (2) the impact of hepatitis C infection on infected children and adolescents. The findings were supplemented by the first-hand experience of the authors.

Findings: Young people, including women of childbearing age, infants, children, and adolescents, are being especially affected by hepatitis C infection secondary to the intravenous drug use and opioid epidemic. Unfortunately, estimates of disease in young populations are all misleading because universal screening has not been implemented.

Implications: Lack of implementation of policies for screening and therapy on most affected populations will be responsible for perpetuation of this infection. In the era of highly effective therapy and a regimen that is approved by the US Food and Drug Administration for children, this outcome is unacceptable.

Keywords: DAAs; HCV; MTCT; direct-acting antiviral; hepatitis C virus; mother-to-child transmission.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Antiviral Agents / therapeutic use*
  • Child
  • Cost-Benefit Analysis
  • Female
  • Hepacivirus
  • Hepatitis C, Chronic / diagnosis
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / epidemiology
  • Hepatitis C, Chronic / transmission*
  • Humans
  • Infant
  • Infectious Disease Transmission, Vertical*
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis
  • Pregnancy Complications, Infectious / drug therapy*
  • United States / epidemiology

Substances

  • Antiviral Agents